glp 1 approval Lilly is now pharma's top revenue company. It just got FDA for an oral GLP-1, but Wall Street isn't celebrating Trends in the Development of

Growth hormone treatment of PraderWilli syndrome has long-term, positive effects on body composition

Reuters coverage: Novo Nordisk Files Patent Infringement Lawsuit At the same time, on Monday, Feburary 9, 2026, Novo Nordisk filed a patent infringement lawsuit against Hims & Hers , alleging that the telehealth companys compounded products infringe U.S

Diabetic neuropathy and the sensory neuron: new aspects of pathogenesis and their treatment implications

It is not FDA-approved

Research indicates that these medications can effectively diminish the desire for beverages, which is particularly beneficial for women experiencing hormonal fluctuations during perimenopause